TY  - JOUR
T1  - Fungal meningitis from injection of contaminated steroids: A compounding problem
AU  - Wilson LE, Blythe D, Sharfstein JM
Y1  - 2012/12/19
N1  - 10.1001/jama.2012.47932
JO  - JAMA
SP  - 2461
EP  - 2462
VL  - 308
IS  - 23
N2  - 
The year is 2002. According to the San Francisco Chronicle, “the case of Doc's Pharmacy illustrates how doctors, as well as their patients, are unaware of the risks inherent in pharmacy compounding.”1 Not long after, the Kansas City Star reviews a series of compounding-related injuries and deaths from across the country. A pharmaceutical industry executive is quoted by the paper as saying, “It is just a matter of time before somebody makes a grossly contaminated product and scores of people die. . . . People will then be asking, ‘Why did this happen?’”2

SN  - 0098-7484
M3  - doi: 10.1001/jama.2012.47932
UR  - http://dx.doi.org/10.1001/jama.2012.47932
ER  -